Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
4-(2-(tert-Butylamino)ethyl)-2-methylphenol, also known as Salbutamol Impurity, is a known impurity of the bronchodilator Salbutamol. This compound serves as a critical reference standard for the identification and quantification of impurities in pharmaceutical formulations. Its detection is essential in ensuring the purity and quality of Salbutamol during analytical assessments in drug development and manufacturing processes. -
Drug Impurity
Levofloxacin impurity 11 is a synthetic impurity associated with Levofloxacin. This compound serves as an important analytical standard for quality control in pharmaceutical research and development. Its characterization is critical for ensuring the purity and efficacy of Levofloxacin formulations, contributing to the overall safety profile of the drug in clinical applications. -
Drug Impurity
Salbutamol impurity 8 (N-Benzyl albuterol) is a chemical impurity associated with the pharmaceutical agent Salbutamol. It serves as a reference standard for the identification and quantification of impurities during quality control processes in drug development and manufacturing. This compound is essential for ensuring the safety and efficacy of Salbutamol formulations in respiratory therapeutic applications. -
Drug Impurity
Clindamycin palmitate impurity 7, also known as Clindamycin stearate, is a characterized drug impurity associated with clindamycin formulations. It is primarily relevant in the assessment of drug purity and quality control processes. This compound is utilized in pharmaceutical research and development to ensure the integrity and safety of antibiotic formulations, providing critical insights into impurity profiles and their potential impact on therapeutic efficacy. -
Drug Intermediate
3-Dimethylaminooxalyl-4-acetylindole serves as an important intermediate in the synthesis of Psilocin and Psilocybin, two significant compounds in psychedelic research. This reagent enables the preparation of these psychoactive substances, facilitating studies on their biological effects and therapeutic potential. Its role as a synthetic precursor is vital for advancing research within the fields of pharmacology and neurobiology. -
Drug Impurity
Budesonide impurity 85, also known as 21-Dehydro budesonide, is a drug impurity associated with the corticosteroid Budesonide. This compound serves as an important analytical standard for quality control in pharmaceutical formulations. Its examination is critical for ensuring the purity of Budesonide products and for assessing their safety and efficacy in clinical applications. -
Drug Impurity
Apixaban Impurity 19 is a chemical impurity associated with the anticoagulant drug Apixaban. This compound is critical for quality control and analytical studies in pharmaceutical research, enabling researchers to assess the purity and safety of Apixaban formulations. It serves as a reference standard for method validation and impurity profiling in drug development and compliance testing. -
Drug Impurity
Alfacalciferol impurity 1 is a characterized impurity associated with the active form of vitamin D, Alfacalciferol. This compound is relevant in the assessment of drug purity and quality control in pharmaceutical formulations that contain Alfacalciferol. Its presence can be significant in understanding the pharmacokinetics and metabolic pathways of vitamin D compounds in biological research. -
Drug Impurity
Betamethasone valerate impurity 2 is a drug impurity associated with Betamethasone valerate. It serves as an important marker for quality control and characterization in pharmaceutical formulations. Its identification and analysis are crucial for ensuring the purity and safety of corticosteroid products used in various therapeutic applications. -
Drug Impurity
Ketoprofen Impurity 1 is a known impurity of the non-steroidal anti-inflammatory drug (NSAID) Ketoprofen. It serves as a valuable standard for quality control and analytical applications in pharmaceutical research. Studying this impurity aids in understanding the metabolic profile and potential degradation pathways of Ketoprofen, ensuring the integrity of formulations containing this compound. -
Drug Impurity
Levetiracetam impurity 3 is a chemical impurity associated with the anticonvulsant drug Levetiracetam. This impurity may be utilized in analytical chemistry studies to assess the purity and stability of Levetiracetam formulations. It is valuable for researchers analyzing drug composition and conducting quality control assessments in pharmaceutical development. -
Drug Impurity
Alfuzosin EP impurity 1 hydrochloride, also known as 2,3,4,5-Tetradehydro alfuzosin hydrochloride, is a recognized impurity of Alfuzosin hydrochloride. This compound is essential for evaluating the purity and stability of alfuzosin formulations in pharmaceutical development. Researchers may utilize this impurity in studies assessing drug quality, pharmacokinetics, and mechanism of action related to alpha-1 adrenergic receptor antagonism. -
Drug Impurity
Imatinib impurity 21 is a known impurity related to the tyrosine kinase inhibitor Imatinib. This compound serves as an important reference standard in analytical chemistry to evaluate the purity and stability of Imatinib formulations. Its analysis is critical for ensuring compliance with regulatory standards in the pharmaceutical industry and for assessing potential biological impacts in drug safety studies. -
Drug Impurity
Azilsartan impurity 31 is a known impurity associated with Azilsartan, an angiotensin II receptor antagonist. This compound is primarily used in pharmaceutical research to ensure the quality and purity of Azilsartan formulations. Its characterization is crucial for regulatory compliance and assessment of potential effects in drug safety evaluations. -
Drug Impurity
Losartan impurity 19, also known as N1-Losartanyl-losartan, is a specific impurity associated with the angiotensin II receptor antagonist Losartan. This compound is used primarily for analytical purposes in quality control and characterization of Losartan formulations. It aids in the assessment of the purity and stability of Losartan products, ensuring compliance with regulatory standards in pharmaceutical research and development. -
Drug Impurity
Levothyroxine impurity 14, also known as 3-Chloro-3’,5,5’-triiodo-L-thyronine, is classified as a drug impurity. This compound may arise during the synthesis or degradation of levothyroxine and is essential for assessing the purity and quality of pharmaceutical formulations. Its identification and quantification are critical in ensuring product safety and efficacy in thyroid hormone therapies. -
Drug Impurity
Crizotinib impurity 1 is a noted impurity associated with the targeted therapy Crizotinib, primarily acting on the anaplastic lymphoma kinase (ALK) and c-MET pathways. This compound is essential for assessing the purity of Crizotinib formulations in pharmaceutical development and quality control. Its analysis is crucial for ensuring compliance with regulatory standards related to drug safety and efficacy. -
Drug Impurity
Levofloxacin impurity 8 is a known impurity of the antibiotic Levofloxacin. It serves as a critical reference standard for assessing the purity and quality of pharmaceutical formulations containing Levofloxacin. This compound is essential for analytical studies and regulatory compliance, particularly in the development and quality control of antibacterial drugs. -
Drug Intermediate
Caspofungin impurity A is a byproduct formed during the synthesis of Caspofungin, a potent antifungal agent targeting β-(1,3)-D-glucan in the fungal cell wall. This impurity serves as a valuable drug intermediate for research and analysis in antifungal drug development. Its study aids in understanding the synthesis process and the characterization of related compounds within the context of pharmaceutical applications. -
Drug Impurity
Olmesartan Impurity 5 is a chemical byproduct associated with the synthesis of Olmesartan, an antihypertensive agent. This impurity serves as a reference standard for quality control and regulatory compliance in pharmaceutical research. It is critical for analytical method development and validation, ensuring the purity and safety of Olmesartan in drug formulations. -
Drug Impurity
Donepezil impurity 13 is a chemical impurity associated with Donepezil, a reversible inhibitor of acetylcholinesterase. It serves as an important reference standard in analytical chemistry for the assessment of pharmaceutical purity. This compound is utilized in the quality control and stability testing of Donepezil formulations, ensuring compliance with regulatory standards in drug development and manufacturing processes. -
Drug Impurity
Grazoprevir impurity 1 is a structural variant of Grazoprevir, a direct-acting antiviral agent targeting the hepatitis C virus (HCV) protease. This impurity is utilized in analytical chemistry for impurity profiling and quality control in pharmaceutical development. Its characterization is essential for ensuring the purity and safety of Grazoprevir formulations in research and clinical applications. -
Drug Impurity
Abacavir impurity 6 is a metabolite of Abacavir, primarily identified as a drug impurity. This compound may be of interest during the quality control and analytical assessment of Abacavir formulations. Its presence can provide insights into the stability and degradation pathways of the active pharmaceutical ingredient in biological and pharmaceutical research. -
Drug Impurity
Candesartan impurity 18 is a known impurity associated with the angiotensin II receptor antagonist, Candesartan. This compound serves as a reference standard for quality control and analytical studies in pharmaceutical development. It is essential for ensuring the integrity and compliance of Candesartan formulations in research and development settings. -
Drug Impurity
Simvastatin impurity 3 is a chemical impurity associated with the cholesterol-lowering agent Simvastatin. This compound is primarily utilized in drug formulation analysis to identify and quantify impurities in the synthesis of Simvastatin. Its presence is critical for ensuring the quality and safety of pharmaceutical products, making it an essential reagent for regulatory compliance and formulation development in the pharmaceutical industry. -
Drug Impurity
Trazodone impurity 19 is a known impurity associated with the antidepressant trazodone. It plays a significant role in quality control and assessment within pharmaceutical development, helping to ensure the purity and safety of drug formulations. This compound can be utilized in research applications to study trazodone's stability and degradation pathways, facilitating the development of more effective antidepressant therapies. -
Drug Impurity
Azilsartan impurity 20, also known as Azilsartan amidoxime, is a chemical impurity associated with the pharmaceutical compound Azilsartan. Its presence is important for ensuring the quality and safety of pharmaceutical formulations. This compound is primarily utilized in quality control and analytical research to assess the purity of Azilsartan and evaluate its synthesis processes. -
Drug Impurity
Sofosbuvir impurity 5 is a known impurity of the antiviral drug Sofosbuvir, which targets the RNA-dependent RNA polymerase of hepatitis C virus. This compound is essential for analytical research and quality control in the development of Sofosbuvir formulations. Its characterization and quantification are important for ensuring the purity and efficacy of the final pharmaceutical product. -
Drug Impurity
Irbesartan impurity 1 is a byproduct associated with the synthesis of Irbesartan, an angiotensin II receptor blocker. This chemical is essential for quality control and method validation in pharmaceutical research and development. Its characterization is crucial for ensuring the safety and efficacy of the final drug product, supporting regulatory compliance and analytical assessments. -
Drug Impurity
Amlodipine impurity 3 is a specific impurity associated with the calcium channel blocker Amlodipine. This compound is significant for drug quality assessments and regulatory compliance in pharmaceutical research. It is utilized in the development and validation of analytical methods for the quantification and characterization of impurities in drug formulations. -
Drug Impurity
Aripiprazole impurity 26, also known as N-(Chloroacetyl)-m-anisidide, is identified as a drug impurity associated with Aripiprazole. This compound is of interest for analytical chemistry and quality control in pharmaceutical research, assisting in the characterization and validation of drug substances. Its presence may be relevant in studying the purity and stability of Aripiprazole formulations. -
Drug Impurity
Candesartan impurity 10 is a structural impurity related to Candesartan, an angiotensin II receptor blocker. This compound is primarily utilized for quality control and analytical purposes in the development and production of Candesartan pharmaceuticals. Its identification and quantification are essential for ensuring the purity and regulatory compliance of Candesartan formulations in drug development. -
Drug Impurity
Salmeterol impurity 4, also known as Salmeterol impurity G, is a known impurity associated with the beta-2 adrenergic agonist Salmeterol. Its presence is important for quality control and analytical studies of Salmeterol formulations. Researchers can utilize this impurity to assess the purity and stability of Salmeterol during drug development processes. -
Drug Impurity
Telmisartan impurity 6 is a synthetic byproduct of Telmisartan, functioning primarily as a drug impurity. It is important for quality control and analytical studies in pharmacological research, assisting in the assessment of pharmaceutical formulations and safety profiles. This impurity is useful in understanding the stability and degradation pathways of Telmisartan, contributing to the overall evaluation of drug quality and efficacy. -
Drug Impurity
Ketoprofen Impurity 7 is a chemical impurity associated with the nonsteroidal anti-inflammatory drug, Ketoprofen. It serves as an important reference standard for method development and validation in pharmaceutical research and quality control. Investigating this impurity facilitates a better understanding of Ketoprofen’s chemical profile, stability, and potential effects on drug performance and safety. -
Drug Impurity
Edoxaban impurity 14, known as (1R,2S,5S)-2-Amino edoxaban, is a chemical impurity of the anticoagulant Edoxaban. This compound is utilized primarily for quality control and analytical purposes in pharmaceutical research. Its characterization and analysis are essential for ensuring the purity and safety of Edoxaban formulations in drug development and regulatory compliance. -
Drug Impurity
Pantoprazole impurity 2, also known as Pantoprazole dimer, serves as a drug impurity associated with Pantoprazole. Its presence is significant in the context of pharmaceutical quality control and stability studies. This compound is utilized in research applications focused on the assessment of drug purity, formulation development, and regulatory compliance in the pharmaceutical industry. -
Drug Impurity
Ciprofloxacin impurity 3 is a known impurity associated with the antibiotic ciprofloxacin. As a drug impurity, it plays a crucial role in analytical chemistry, particularly in the development and validation of analytical techniques for residual impurity quantification in pharmaceutical formulations. Understanding and characterizing such impurities is essential for ensuring the safety and efficacy of ciprofloxacin in clinical applications. -
Drug Impurity
Prednisolone Impurity 4 is a structural impurity associated with the corticosteroid Prednisolone. This compound is relevant in pharmaceutical research for the characterization and analysis of drug formulations. It serves as a reference standard in the assessment of drug purity and stability during quality control processes. -
Drug Impurity
Apixaban impurity 49 is a chemical impurity associated with the anticoagulant agent Apixaban. This compound is crucial for quality control and analytical applications within pharmaceutical research, enabling the assessment of impurity profiles and compliance with regulatory standards. It serves as an important reference standard for the development and validation of analytical methods in drug formulation and stability studies. -
Drug Impurity
Rivastigmine impurity 5 is a designated impurity associated with the cholinesterase inhibitor Rivastigmine. This compound serves as a critical reference standard for quality control and analytical chemistry in pharmaceutical research. Its analysis is essential for ensuring the purity of Rivastigmine formulations, thereby supporting regulatory compliance and safety assessments in drug development. -
Drug Impurity
Doxepin impurity 1 hydrochloride is a chemical impurity associated with Doxepin, a tricyclic antidepressant. Its identification and characterization are crucial for ensuring the purity and safety of pharmaceutical formulations. This reagent provides essential insights into drug quality control and is primarily utilized in analytical chemistry and pharmacological research to assess the presence and concentration of impurities in drug substances. -
Drug Impurity
Exatecan intermediate 13 is a known impurity of the chemotherapeutic agent Exatecan, which primarily targets DNA topoisomerase I. This compound serves as a valuable research tool for the study of drug impurities and their impact on pharmacological activity. It is essential for assessing the purity of Exatecan in drug development and evaluating potential effects on efficacy and safety profiles in cancer research applications. -
Drug Impurity
Acyclovir impurity 1 is a chemical impurity associated with the antiviral drug Acyclovir. This reagent is essential for quality control and analytical studies in the development and assessment of Acyclovir formulations. Its identification and characterization contribute to ensuring the purity and safety of antiviral therapeutics. -
Drug Impurity
Quetiapine impurity 8 (9-Chloro quetiapine) is a identified impurity of the antipsychotic drug Quetiapine. Its presence is relevant in the quality control and pharmacokinetic studies of Quetiapine formulations. The characterization of such impurities is essential for ensuring the safety and efficacy of pharmaceutical preparations in drug development and regulatory compliance. -
Drug Impurity
Donepezil impurity 1, also known as 3-Hydroxy donepezil, is a chemical impurity associated with the pharmacological agent Donepezil. It serves as an important analytical standard for quality control in pharmaceutical research, enabling the detection and quantification of impurities in Donepezil formulations. Its presence can impact the efficacy and safety profiles of the final drug products, making it essential for compliance in regulatory assessments and stability studies. -
Drug Impurity
Desmethylcitalopram hydrobromide is a notable drug impurity associated with the selective serotonin reuptake inhibitor (SSRI) citalopram. Its primary mechanism involves the modulation of serotonin levels in the central nervous system. This compound is significant for analytical chemistry studies focused on drug formulation, quality control, and pharmacokinetic research, providing insights into drug metabolism and safety profiles. -
Drug Impurity
Allopurinol impurity 2 is a known impurity associated with the drug Allopurinol, which primarily functions as a xanthine oxidase inhibitor. This compound is utilized in chemical research to study drug purity, stability, and potential side effects. Its characterization is essential for ensuring the quality and efficacy of Allopurinol formulations in therapeutic applications. -
Drug Impurity
Medroxyprogesterone acetate impurity 4 is an impurity associated with Medroxyprogesterone acetate, a synthetic progestin. This compound serves as a pivotal reference material for analytical studies and quality control in pharmaceutical development. Its characterization is crucial for understanding the purity and safety profiles of progestin-based formulations. -
Drug Impurity
Clindamycin palmitate impurity 12 (Clindamycin 2,3-dipalmitate) is a known drug impurity associated with clindamycin formulations. This compound can be utilized in analytical studies to assess the quality and stability of clindamycin products. Its presence may have implications for drug efficacy and safety, making it relevant for research into pharmaceutical formulations and impurity profiling.
